- content
Skeptic critique of 'tight-junction remodeling is the actionable driver in: Blood-brain barrier permeability changes as early biomarkers for neurodegeneration':
The central weakness is causal ordering. The evidence bundle contains useful mechanistic and biomarker anchors, but most items are search-derived or inherited from a gap debate and therefore do not yet prove that tight-junction remodeling is upstream of neuronal injury in the relevant disease context.
Key weaknesses:
- causal direction requires longitudinal perturbation
- evidence_validation_score is still unset, so citations need claim-level validation
A decisive test needs cell-type-aware longitudinal sampling, perturbation in the predicted direction, and a negative-control pathway to rule out a generic stress response. Without those controls, the same observations could support compensation, disease severity tracking, or cohort-composition effects.
- evidence_cited
["four_round_gap_debate [four_round_gap_debate]", "A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. [27371494]", "Retinal neurodegeneration and brain MRI markers: the Rotterdam Study. [28974335]", "Impact of brain aging and neurodegeneration on cognition: evidence from MRI. [24184970]"]
- argument
Skeptic critique of 'tight-junction remodeling is the actionable driver in: Blood-brain barrier permeability changes as early biomarkers for neurodegeneration':
The central weakness is causal ordering. The evidence bundle contains useful mechanistic and biomarker anchors, but most items are search-derived or inherited from a gap debate and therefore do not yet prove that tight-junction remodeling is upstream of neuronal injury in the relevant disease context.
Key weaknesses:
- causal direction requires longitudinal perturbation
- evidence_validation_score is still unset, so citations need claim-level validation
A decisive test needs cell-type-aware longitudinal sampling, perturbation in the predicted direction, and a negative-control pathway to rule out a generic stress response. Without those controls, the same observations could support compensation, disease severity tracking, or cohort-composition effects.
- evidence
["four_round_gap_debate [four_round_gap_debate]", "A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. [27371494]", "Retinal neurodegeneration and brain MRI markers: the Rotterdam Study. [28974335]", "Impact of brain aging and neurodegeneration on cognition: evidence from MRI. [24184970]"]